Computed Tomography-based 3D Convolutional Neural Network Deep Learning Model for Predicting Micropapillary or Solid Growth Pattern of Invasive Lung Adenocarcinoma
Overview
Authors
Affiliations
Purpose: To investigate the value of a computed tomography (CT)-based deep learning (DL) model to predict the presence of micropapillary or solid (M/S) growth pattern in invasive lung adenocarcinoma (ILADC).
Materials And Methods: From June 2019 to October 2022, 617 patients with ILADC who underwent preoperative chest CT scans in our institution were randomly placed into training and internal validation sets in a 4:1 ratio, and 353 patients with ILADC from another institution were included as an external validation set. Then, a self-paced learning (SPL) 3D Net was used to establish two DL models: model 1 was used to predict the M/S growth pattern in ILADC, and model 2 was used to predict that pattern in ≤ 2-cm-diameter ILADC.
Results: For model 1, the training cohort's area under the curve (AUC), accuracy, recall, precision, and F1-score were 0.924, 0.845, 0.851, 0.842, and 0.843; the internal validation cohort's were 0.807, 0.744, 0.756, 0.750, and 0.743; and the external validation cohort's were 0.857, 0.805, 0.804, 0.806, and 0.804, respectively. For model 2, the training cohort's AUC, accuracy, recall, precision, and F1-score were 0.946, 0.858, 0.881,0.844, and 0.851; the internal validation cohort's were 0.869, 0.809, 0.786, 0.794, and 0.790; and the external validation cohort's were 0.831, 0.792, 0.789, 0.790, and 0.790, respectively. The SPL 3D Net model performed better than the ResNet34, ResNet50, ResNeXt50, and DenseNet121 models.
Conclusion: The CT-based DL model performed well as a noninvasive screening tool capable of reliably detecting and distinguishing the subtypes of ILADC, even in small-sized tumors.
Wu D, Li Y, Zhou M, Gong F, Li J BMC Cancer. 2024; 24(1):1229.
PMID: 39369213 PMC: 11453012. DOI: 10.1186/s12885-024-13018-7.
Huang H, Yan Z, Li B, Lu W, He P, Fan L Transl Lung Cancer Res. 2024; 13(8):1816-1827.
PMID: 39263012 PMC: 11384487. DOI: 10.21037/tlcr-24-258.